Prevención primaria de enfermedades cardiovascularesuna revisión de revisiones de intervenciones no farmacológicas

  1. Martin Ruiz, E. 1
  2. Olry de Labry, A. 2
  3. Epstein, D. 3
  1. 1 Escuela Andaluza de Salud Pública
    info

    Escuela Andaluza de Salud Pública

    Granada, España

  2. 2 Escuela Andaluza de Salud Pública CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Instituto de Investigación Biosanitaria ibs.Granada. Hospitales Universitarios de Granada/ Universidad de Granada, Granada, Spain.
  3. 3 Facultad de Ciencias Económicas. Universidad de Granada. Campus Universitario de Cartuja. Granada, Spain.
Mostrar afiliaciones +
Revista:
Anales del sistema sanitario de Navarra

ISSN: 1137-6627

Año de publicación: 2018

Volumen: 41

Número: 3

Páginas: 355-369

Tipo: Artículo

DOI: 10.23938/ASSN.0316 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Anales del sistema sanitario de Navarra

Objetivos de desarrollo sostenible

Resumen

Fundamento. El objetivo de este estudio es determinar la efectividad de intervenciones no farmacológicas para la prevención de eventos relacionados con enfermedad cardiovascular (CVD), y mortalidad en adultos sanos o con alto riesgo de CVD.Método. Revisión de revisiones sobre prevención primaria de intervenciones no farmacológicas en las bases de datos de PubMed Health, Effective Health Care Program AHRQ, McMaster University and the Cochrane Plus hasta Julio de 2017. Los resultados primarios fueron el riesgo relativo de eventos CVD, fatales y no fatales, y de mortalidad; los efectos adversos fueron los eventos secundarios.Resultados. Se incluyeron veinticuatro revisiones, de las cuales trece informan resultados de interés. Cuatro observaron una reducción significativa del riesgo: suplementación de vitamina D, incremento del consumo de ácidos grasos omega 3, Qigong, y educación para la modificación de factores de riesgo cardiovascular. Siete revisiones informaron sobre eventos adversos menores y/o no significativos respecto del grupo control.Conclusiones. Cuatro intervenciones no farmacológicas son las que muestran una reducción estadísticamente significativa en eventos CVD o mortalidad total, con escasos o nulos efectos adversos. Se requiere de una investigación de mayor calidad metodológica y de mayor seguimiento de las intervenciones para establecer si estas, combinadas o por separado, conducen a claros beneficios en salud a largo plazo. Palabras clave. Cardiovascular. Intervención no-prescrita. Revisión de revisiones. Revisiones sistemáticas y meta-análisis.

€ Ver financiación

Información de financiación

This study was financed by the EPIC-CVD project under the European Commission. Directorate General for Research & Innovation FP 7 Health 2011. Grant Agreement number 279233.

Financiadores

Referencias bibliográficas

  • ROBINSON JG. Starting primary prevention earlier with statins. Am J Cardiol 2014; 114:1437-1442.
  • NICE guidelines could put 12 million UK adults on statins. BMJ 2017; 358: j3674.
  • GOLDACRE B. Mass treatment with statins. BMJ 2014; 349: g4745.
  • TOWNSEND N, NICHOLS M, SCARBOROUGH P, RAYNER M. Cardiovascular disease in Europe 2015: epidemiological update. Eur Heart J 2015; 36: 2673-2674.
  • WHO, United States Centers for Disease Control and Prevention (US CDC) Global Hearts Initiative. Working together to beat cardiovascular disease. [Access on: 20/03/2017] Available from http://www.who.int/cardiovascular_diseases/global-hearts/en/
  • THE JOANNA BRIGGS INSTITUTE. Joanna Briggs Institute Reviewers’ Manual: 2014 edition. Supplement. Adelaide: The Joanna Briggs Institute 2014. [Accessed 01/09/2017]. Available from: http://joannabriggs.org/assets/docs/sumari/ReviewersManual-Methodology-JBI_Umbrella%20Reviews-2014.pdf
  • SMITH V, DEVANE D, BEGLEY CM, CLARKE M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol 2011; 11: 15. DOI: 10.1186/1471-2288-11-15.
  • SHEA BJ, GRIMSHAW JM, WELLS GA, BOERS M, ANDERSSON N, HAMEL C ET AL. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7: 10. DOI: 10.1186/1471-2288-7-10.
  • HIGGINS JP, THOMPSON SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002; 21: 1539-1558.
  • KETOLA E, SIPILÄ R, MÄKELÄ M. Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors. Ann Med 2000; 32: 239-251.
  • EBRAHIM S, TAYLOR F, WARD K, BESWICK A, BURKE M, DAVEY SMITH G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011; 1. CD001561. DOI: 10.1002/14651858.CD001561.pub3.
  • AL-KHUDAIRY L, FLOWERS N, WHEELHOUSE R, GHANNAM O, HARTLEY L, STRANGES S ET AL. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2017; 3. CD011114. DOI: 10.1002/14651858.CD011114.pub2.
  • BJELAKOVIC G, NIKOLOVA D, GLUUD LL, SIMONETTI RG, GLUUD C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012: 3: CD007176. doi: 10.1002/14651858.CD007176.pub2.
  • BJELAKOVIC G, GLUUD LL, NIKOLOVA D, WHITFIELD K, WETTERSLEV J, SIMONETTI RG ET AL. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014; 1. CD007470. DOI: 10.1002/14651858.CD007470.pub2.
  • REES K, HARTLEY L, DAY C, FLOWERS N, CLARKE A, STRANGES S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 1. CD009671. DOI: 10.1002/14651858.CD009671.pub2.
  • FLOWERS N, HARTLEY L, TODKILL D, STRANGES S, REES K. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 12. CD010405. DOI: 10.1002/14651858.CD010405.pub2.
  • HARTLEY L, CLAR C, GHANNAM O, FLOWERS N, STRANGES S, REES K. Vitamin K for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 9. CD011148. DOI: 10.1002/14651858.CD011148.pub2.
  • FORTMANN SP, BURDA BU, SENGER CA, LIN JS, WHITLOCK EP. Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Evidence Review for the U.S. Ann Intern Med 2013; 159: 824-834.
  • HOOPER L, BARTLETT C, DAVEY SMITH G, EBRAHIM S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev 2004; 1. CD003656. DOI: 10.1002/14651858.CD003656.pub2.
  • HARTLEY L, IGBINEDION E, HOLMES J, FLOWERS N, THOROGOOD M, CLARKE A. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases. Cochrane Database Syst Rev 2013; 6. CD009874. DOI: 10.1002/14651858.CD009874.pub2.
  • REES K, HARTLEY L, FLOWERS N, CLARKE A, HOOPER L, THOROGOOD M ET AL. 'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 8. CD009825.
  • MARTIN N, GERMANÒ R, HARTLEY L, ADLER AJ, REES K. Nut consumption for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 9. CD011583. DOI: 10.1002/14651858.CD011583.pub2.
  • HARTLEY L, FLOWERS N, HOLMES J, CLARKE A, STRANGES S, HOOPER L ET AL. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 6.CD009934. DOI: 10.1002/14651858.CD009934.pub2.
  • HARTLEY L, MAY MD, LOVEMAN E, COLQUITT JL, REES K. Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2016; 1.CD011472. DOI: 10.1002/14651858.CD011472.pub2.
  • HOOPER L, THOMPSON RL, HARRISON RA, SUMMERBELL CD, MOORE H, WORTHINGTON HV ET AL. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004; 4.CD003177. DOI: 10.1002/14651858.CD003177.pub2.
  • AL-KHUDAIRYL, HARTLEY L, CLAR C, FLOWERS N, HOOPER L, REES K. Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 11.CD011094. DOI: 10.1002/14651858.CD011094.pub2.
  • UTHMAN OA, HARTLEY L, REES K, TAYLOR F, EBRAHIM S, CLARKE A. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. Cochrane Database Syst Rev 2015; 8. DOI: 10.1002/14651858.CD011163.pub2.
  • SERON P, LANAS F, PARDO-HERNANDEZ H, BONFILL COSP X. Exercise for people with high cardiovascular risk. Cochrane Database Syst Rev 2014; 8.CD009387. DOI: 10.1002/14651858.CD009387.pub2.
  • HARTLEY L, LEE MS, KWONG JSW, FLOWERS N, TODKILL D, ERNST E ET AL. Qigong for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2015; 6.CD010390. DOI: 10.1002/14651858.CD010390.pub2.
  • HARTLEY L, FLOWERS N, LEE MS, ERNST E, REES K. Tai chi for primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 4.CD010366. DOI: 10.1002/14651858.CD010366.pub2.
  • HARTLEY L, DYAKOVA M, HOLMES J, CLARKE A, LEE MS, ERNST E ET AL. Yoga for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 5.CD010072. DOI: 10.1002/14651858.CD010072.pub2.
  • HARTLEY L, MAVRODARIS A, FLOWERS N, ERNST E, REES K. Transcendental meditation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014; 12.CD010359. DOI: 10.1002/14651858.CD010359.pub2.
  • WIDMER RJ, COLLINS NM, COLLINS CS, WEST CP, LERMAN LO, LERMAN A. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc 2015; 90: 469-480. DOI: 10.1016/j.mayocp.2014.12.026.
  • KROGSBØLL LT, JØRGENSEN KJ, GRØNHØJ LARSEN C, GØTZSCHE PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012; 10.CD009009. DOI: 10.1002/14651858.CD009009.pub2.
  • NQA.ORG. What is Qigong?. National Qigong Association. [online] Available from: http://www.nqa.org/ [Accessed 22/09/2017].
  • THEODORATOU E, TZOULAKI I, ZGAGA L, IOANNIDIS JPA. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014; 1: g2035. DOI: https://doi.org/10.1136/bmj.g2035.
  • SEUNG-KWON M, WOONG J, BELONG C, SEUNG-WON O, SANG MIN P, BON-KWON K ET AL. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 346: f10. DOI: https://doi.org/10.1136/bmj.f10.
  • BROWN WV, BAYS HE, LA FORGE R, SIKAND G. JCL Roundtable. Gender differences in risk reduction with lifestyle changes. J Clin Lipidol 2015; 9: 486-495.
  • SOMMER I, GRIEBLER U, MAHLKNECHT P, THALER K, BOUSKILL K, GARTLEHNER G ET AL. Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health 2015; 15: 914. DOI: 10.1186/s12889-015-2227-y.
Fuente de los datos: Dialnet